» Articles » PMID: 15207059

Newborn Screening for Congenital Infectious Diseases

Overview
Date 2004 Jun 23
PMID 15207059
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

To estimate the prevalence of congenital toxoplasmosis, Chagas disease, cytomegalovirus, and rubella, blood samples on dried blood spot (DBS) from neonates (day 3-20 of life) were screened for immunoglobulin (Ig) M against Toxoplasma gondii, cytomegalovirus, rubella virus, and IgG against Trypanosoma cruzi by methods used for serum and adapted for use with DBS. Positive samples were further analyzed for IgM and IgG in serum from neonates and mothers. DBS samples from 364,130 neonates were tested for Toxoplasma gondii-specific IgM, and 15,873 neonates were also tested for IgM against cytomegalovirus and rubella virus and for Trypanosoma cruzi-specific IgG. A total of 195 were diagnosed with congenital toxoplasmosis, 16 with cytomegalovirus, and 11 with congenital rubella. One newborn had a confirmed result for Chagas disease, and 21 mothers had positive serum antibodies. These results suggest that infectious diseases should be considered for future inclusion in programs for newborn screening of metabolic diseases in disease-endemic areas.

Citing Articles

Shadow of a Pandemic: Persistence of Prenatal SARS-CoV-2 Antibodies in Newborn Blood Spots.

Sciortino S, Graham S, Fillman T, Kandasamy H, Cooley R, Hanson C Int J Neonatal Screen. 2023; 9(3).

PMID: 37606480 PMC: 10443380. DOI: 10.3390/ijns9030043.


Arboviruses as an unappreciated cause of non-malarial acute febrile illness in the Dschang Health District of western Cameroon.

Ali I, Tchuenkam V, Colton M, Stittleburg V, Mitchell C, Gaither C PLoS Negl Trop Dis. 2022; 16(10):e0010790.

PMID: 36223421 PMC: 9591055. DOI: 10.1371/journal.pntd.0010790.


Rapid method towards proteomic analysis of dried blood spots by MALDI mass spectrometry.

Samenuk G, Kelley A, Perry G, Bach S Clin Mass Spectrom. 2021; 12:30-36.

PMID: 34841077 PMC: 8620524. DOI: 10.1016/j.clinms.2019.03.002.


Congenital Toxoplasmosis: Findings in Fetal MRI.

Lazarte-Rantes C, Rodriguez-Anccasi R, Rivas-Campos C, Silva E Cureus. 2021; 13(8):e16894.

PMID: 34513467 PMC: 8417349. DOI: 10.7759/cureus.16894.


Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections.

Dubey J, Murata F, Cerqueira-Cezar C, Kwok O, Villena I Parasitology. 2021; 148(12):1406-1416.

PMID: 34254575 PMC: 11010219. DOI: 10.1017/S0031182021001013.


References
1.
Russomando G, de Tomassone M, De Guillen I, Acosta N, Vera N, Almiron M . Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg. 1998; 59(3):487-91. DOI: 10.4269/ajtmh.1998.59.487. View

2.
Frey T . Neurological aspects of rubella virus infection. Intervirology. 1997; 40(2-3):167-75. DOI: 10.1159/000150543. View

3.
Lebech M, Andersen O, Christensen N, Hertel J, Nielsen H, Peitersen B . Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group . Lancet. 1999; 353(9167):1834-7. DOI: 10.1016/s0140-6736(98)11281-3. View

4.
Cutts F, Vynnycky E . Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol. 2000; 28(6):1176-84. DOI: 10.1093/ije/28.6.1176. View

5.
Basombrio M, NASSER J, Segura M, Marco D, Sanchez Negrette O, Padilla M . [The transmission de Chagas disease in Salta and the detection of congenital cases]. Medicina (B Aires). 2000; 59 Suppl 2:143-6. View